Register Cart 0

Generic placeholder image

Recent Patents on Inflammation & Allergy Drug Discovery

Editor-in-Chief

ISSN (Print): 1872-213X
ISSN (Online): 2212-2710

Back Subscribe

Patent Selections

Author(s): Bentham Science Publishers

Volume 5, Issue 3, 2011

Page: [253 - 255] Pages: 3

DOI: 10.2174/187221311797264946

Open Access Journals Promotions 2

conference banner

« Previous

Rights & Permissions Print Cite

Article Metrics

9

Related Articles

RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry

Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy
Clinical Cancer Drugs

Applications of Computed Tomography, Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy for Planning External Beam Radiotherapy
Current Medical Imaging

Recent Advances in Physical Delivery Enhancement of Topical Drugs
Current Pharmaceutical Design

Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design

MicroRNA-31 Inhibits Lung Adenocarcinoma Stem-Like Cells via Down-Regulation of MET-PI3K-Akt Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry

Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics

LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy
Current Cancer Drug Targets

Novel Approaches Towards Designing of Isoform-Selective Inhibitors Against Class II Histone Deacetylases: The Acute Requirement for Targetted Anticancer Therapy
Current Topics in Medicinal Chemistry

Therapeutic Antibodies
Current Molecular Medicine

Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Current Medicinal Chemistry

Platinum-Based Agents for Individualized Cancer Treatment
Current Molecular Medicine

Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment
Current Cancer Drug Targets

PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?
Current Pharmaceutical Design

Phytoestrogens and Prostate Cancer
Current Drug Targets

The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design

Management of Early Stage Cervical Cancer
Reviews on Recent Clinical Trials

Interactions Between Proteins and Platinum-Containing Anti-Cancer Drugs
Mini-Reviews in Medicinal Chemistry

Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
Current Cancer Drug Targets

Nitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives
Current Topics in Medicinal Chemistry

© 2024 Bentham Science Publishers | Privacy Policy